Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly.
1. STOCK NEWS:
- Tesla (TSLA) officially delivered its first Model S Plaid vehicles during a Thursday event [more]
- Vertex (VRTX) ended development of liver disease drug VX-864 [more]
- MagnaChip (MX) confirmed receipt of a $35 per share acquisition offer from Cornucopia Investment [more]
- China's DiDi (DIDI) intends to list American depositary shares on Nasdaq or NYSE [more]
- Moderna (MRNA) said that it finds no "causal association" between its mRNA vaccine against COVID-19 and myocarditis [more]
2. TOP CALLS:
- Vaxart (VXRT) was initiated with an Overweight rating at Piper Sandler [more]
- Morgan Stanley analyst Katy Huberty downgraded Logitech (LOGI) and Cricut (CRCT) to Equal Weight as part of her broader view on the IT hardware industry [more]
- Citi analyst Mark Li downgraded TAL Education (TAL) and Gaotu Techedu (GOTU) to Sell on Chinese government regulation risk [more]
- Bernstein analyst Aaron Gal upgraded Biogen (BIIB) to Outperform from Market Perform [more]
- BofA analyst Ronald Epstein upgraded Embraer (ERJ) to Buy on "significant" eVTOL opportunity [more]
3. AROUND THE WEB:
- MKS Instruments (MKSI) approached Atotech (ATC) with an acquisition offer only months after Atotech's float, Reuters reports [more]
- McDonald's (MCD) was hit by a data breach in South Korea and Taiwan, WSJ says [more]
- Clover Health (CLOV) founders have been accused of overcharging patients at New Jersey hospitals, NY Post reports [more]
- Thrasio is in talks to go public via a deal with Churchill Capital Corp V (CCV) SPAC, Bloomberg says [more]
- Medallia (MDLA) is exploring a potential sale of the company, Bloomberg reports [more]
4. MOVERS:
- Precigen (PGEN) rises after subsidiary Precigen ActoBio released results for its ongoing Phase 1b/2a clinical trial studying AC019 ActoBiotics for the treatment of type-1 diabetes [more]
- Autolus Therapeutics (AUTL) gains after presenting new data on obe-cel in relapsed / refractory indolent B cell lymphomas and in relapsed / refractory adult Acute Lymphoblastic Leukemia [more]
- AbCellera (ABCL) higher after filing to sell 12M shares of its common stock for holders [more]
- Curis (CRIS) lower after reporting data from its ongoing Phase 1/2 trial of CA-4948 [more]
- Snowflake (SNOW) drops after analysts react to yesterday’s analyst day meeting [more]
5. EARNINGS:
- Chewy (CHWY) slips after "beat and raise" quarterly report [more]
- Dave & Buster's (PLAY) rises after reporting upbeat Q1 results [more]
- Navigator Holdings (NVGS) lower after reporting Q1 results [more]
- Mission Produce (AVO) higher after providing upbeat FY21 revenue guidance [more]
- Nathan's Famous (NATH) falls after reporting y/y earnings decline in Q4 [more]
INDEXES:
The Dow rose 13.36, or 0.039%, to 34,479.60, the Nasdaq gained 49.09, or 0.35%, to 14,069.42, and the S&P 500 advanced 8.26, or 0.19%, to 4,247.44.